BioMerieux SA/ FR0013280286 /
| 2024-11-08 5:35:48 PM | Chg. +1.00 | Volume | Bid5:41:20 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 102.30EUR | +0.99% | 168,491 Turnover: 9.82 mill. |
101.60Bid Size: 250 | 102.50Ask Size: 97 | 12.11 bill.EUR | 0.83% | 33.76 |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 711.4000 | 807.5000 | 894.7000 | 939 | 1,224.8000 | ||||||
| Intangible Assets | 430.7000 | 507.3000 | 508.4000 | 430.7000 | 411.5000 | ||||||
| Long-Term Investments | 57.9000 | 71.8000 | 41.9000 | 50.6000 | - | ||||||
| Fixed Assets | 1,708.5000 | 2,093.9000 | 2,343.5000 | 2,266.3000 | 2,412.5000 | ||||||
| Inventories | 380.3000 | 414.9000 | 494.7000 | 541.9000 | 620 | ||||||
| Accounts Receivable | 460.1000 | 490 | 552.1000 | 597.9000 | 590.6000 | ||||||
| Cash and Cash Equivalents | 312.1000 | 280.1000 | 275 | 389.2000 | 803.5000 | ||||||
| Current Assets | 1,279.4000 | 1,295.6000 | 1,438.5000 | 1,661.6000 | 2,184.6000 | ||||||
| Total Assets | 2,990 | 3,389.6000 | 3,781.9000 | 3,927.8000 | 4,605 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 161.3000 | 176.9000 | 211.9000 | 207.1000 | 239.5000 | ||||||
| Long-term debt | 391.1000 | 446.8000 | 153.7000 | 352.4000 | 362.8000 | ||||||
| Liabilities to Banks | 468 | 547 | 592.3000 | 481.3000 | - | ||||||
| Provisions | 244.6000 | 136 | 141.2000 | 105.8000 | 174.3000 | ||||||
| Liabilities | 1,253.3000 | 1,386.3000 | 1,527.3000 | 1,446.5000 | 1,441.4000 | ||||||
| Share Capital | 12 | 12 | 12 | 12 | - | ||||||
| Total Equity | 1,737.6000 | 1,929.3000 | 2,203.9000 | 2,431.1000 | 3,163.6000 | ||||||
| Minority Interests | -.9000 | 74 | 50.7000 | 50.2000 | - | ||||||
| Total liabilities equity | 2,990 | 3,389.6000 | 3,781.9000 | 3,927.8000 | 4,605 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,288.2000 | 2,421.3000 | 2,674.8000 | 3,118.2000 | 3,376.2000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 314.9000 | 343.6000 | 370.7000 | 595.1000 | 784.3000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 292.1000 | 320.8000 | 347.5000 | 524.4000 | - | ||||||
| Income Taxes | -54.5000 | -65.2000 | -77.8000 | -121.7000 | 175.6000 | ||||||
| Minority Interests Profit | .6000 | 1.1000 | 3.1000 | 1.7000 | 2.9000 | ||||||
| Net Income | 238.1000 | 256.6000 | 272.8000 | 404.4000 | 601.1000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 357.5000 | 386.9000 | 407.9000 | 582.8000 | 824.7000 | ||||||
| Cash Flow from Investing Activities | -180.4000 | -418.2000 | -282.2000 | -265.2000 | -307.3000 | ||||||
| Cash Flow from Financing | -68.7000 | 52.7000 | -133.9000 | -176.2000 | -140.6000 | ||||||
| Decrease / Increase in Cash | 108.4000 | 21.4000 | -8.2000 | 141.4000 | - | ||||||
| Employees | 10,321 | 11,029 | 12,000 | 13,000 | 12,379 | ||||||
